These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
4. Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression. Brust P; Haubner R; Friedrich A; Scheunemann M; Anton M; Koufaki ON; Hauses M; Noll S; Noll B; Haberkorn U; Schackert G; Schackert HK; Avril N; Johannsen B Eur J Nucl Med; 2001 Jun; 28(6):721-9. PubMed ID: 11440032 [TBL] [Abstract][Full Text] [Related]
5. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Tjuvajev JG; Avril N; Oku T; Sasajima T; Miyagawa T; Joshi R; Safer M; Beattie B; DiResta G; Daghighian F; Augensen F; Koutcher J; Zweit J; Humm J; Larson SM; Finn R; Blasberg R Cancer Res; 1998 Oct; 58(19):4333-41. PubMed ID: 9766661 [TBL] [Abstract][Full Text] [Related]
6. Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Hackman T; Doubrovin M; Balatoni J; Beresten T; Ponomarev V; Beattie B; Finn R; Bornmann W; Blasberg R; Tjuvajev JG Mol Imaging; 2002; 1(1):36-42. PubMed ID: 12920859 [TBL] [Abstract][Full Text] [Related]
7. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Jacobs A; Dubrovin M; Hewett J; Sena-Esteves M; Tan CW; Slack M; Sadelain M; Breakefield XO; Tjuvajev JG Neoplasia; 1999 Jun; 1(2):154-61. PubMed ID: 10933050 [TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy. Blasberg RG; Tjuvajev JG Q J Nucl Med; 1999 Jun; 43(2):163-9. PubMed ID: 10429512 [TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU. Haubner R; Avril N; Hantzopoulos PA; Gansbacher B; Schwaiger M Eur J Nucl Med; 2000 Mar; 27(3):283-91. PubMed ID: 10774880 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Tjuvajev JG; Finn R; Watanabe K; Joshi R; Oku T; Kennedy J; Beattie B; Koutcher J; Larson S; Blasberg RG Cancer Res; 1996 Sep; 56(18):4087-95. PubMed ID: 8797571 [TBL] [Abstract][Full Text] [Related]
11. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir. Deng WP; Yang WK; Lai WF; Liu RS; Hwang JJ; Yang DM; Fu YK; Wang HE Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):99-109. PubMed ID: 14513292 [TBL] [Abstract][Full Text] [Related]
13. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Rainov NG Hum Gene Ther; 2000 Nov; 11(17):2389-401. PubMed ID: 11096443 [TBL] [Abstract][Full Text] [Related]
14. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307 [TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer. Bennett JJ; Tjuvajev J; Johnson P; Doubrovin M; Akhurst T; Malholtra S; Hackman T; Balatoni J; Finn R; Larson SM; Federoff H; Blasberg R; Fong Y Nat Med; 2001 Jul; 7(7):859-63. PubMed ID: 11433353 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of F-18-labeled 5-iodocytidine (18F-FIAC) as a new potential positron emission tomography probe for herpes simplex virus type 1 thymidine kinase imaging. Chan PC; Wu CY; Chang WY; Chang WT; Alauddin M; Liu RS; Lin WJ; Chen FD; Chen CL; Wang HE Nucl Med Biol; 2011 Oct; 38(7):987-95. PubMed ID: 21982570 [TBL] [Abstract][Full Text] [Related]
17. A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Klatzmann D; Valéry CA; Bensimon G; Marro B; Boyer O; Mokhtari K; Diquet B; Salzmann JL; Philippon J Hum Gene Ther; 1998 Nov; 9(17):2595-604. PubMed ID: 9853526 [TBL] [Abstract][Full Text] [Related]